Conservative treatment of early postoperative small bowel obstruction with obliterative peritonitis

Table 3 Outcomes of patients receiving total parenteral nutrition alone or in combination with somatostatin and dexamethasone

	TPN (n = 34)	TDS (n = 36)	P value
Time to obstruction resolution (d)	29.9 ± 10.1 (17-60)	22.4 ± 9.1 (13-52)	0.002
Length of hospital stay (d)	34.7 ± 11.2 (21-69)	25.8 ± 9.9 (16-57)	0.001
Daily NG output (mL)1	922 ± 399 (400-1825)	583 ± 208 (150-1050)	< 0.001
Mean NG duration (d)	27.7 ± 9.9 (7-54)	16.7 ± 8.8 (3-42)	< 0.001
Relapse of obstruction
1 yr after operation (n/N)2	3/32	2/34	0.668
2 yr after operation (n/N)3	6/29	5/31	0.745
3 yr after operation (n/N)4	8/27	6/28	0.547
Postoperative satisfaction ≥ 35
1 yr after operation (n/N)2	22/32	20/34	0.451
2 yr after operation (n/N)3	15/29	14/31	0.796
3 yr after operation (n/N)4	11/27	10/28	0.785

¹Mean value of the first 2 d after NG tube placement;

²TPN (n = 32, 1 patient was lost to follow-up, and 1 died of malignancy); TDS (n = 34, 2 patients were lost to follow-up);

³TPN (n = 29, 2 patients were lost to follow-up, and 1 died of malignancy); TDS (n = 31, 3 patients were lost to follow-up);

⁴TPN (n = 27, 2 patients were lost to follow-up); TDS (n = 28, 2 patients were lost to follow-up and 1 died of cardiovascular disease);

⁵Patients with satisfaction ≥ 3 were satisfied (3) or very satisfied (4). TDS: TPN + DM + SS; TPN: Total parenteral nutrition; DM: Dexamethasone; SS: Somatostatin; NG: Nasogastric.